JIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting

Bulletin Express

Mar 25

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The decision follows feedback from certain shareholders requesting additional time to evaluate the scheme. Management indicated that the share award programme is neither essential nor time-sensitive at this stage.

As a direct consequence of the withdrawal, the extraordinary general meeting (EGM) originally slated for 8 April 2026 at 14:30 in Hangzhou has been cancelled. The company issued an apology to shareholders for any inconvenience caused.

The board currently comprises two executive directors (Mr. Fu Hang, Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, Ms. Yan Weiting) and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, Dr. Zhou Demin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1164747939"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164747939\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164747939?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 12:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164747939","market":"us","top_or_hot":-1,"title":"JIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting","media":"Bulletin Express","content":"<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The decision follows feedback from certain shareholders requesting additional time to evaluate the scheme. Management indicated that the share award programme is neither essential nor time-sensitive at this stage.</p>\n<p>As a direct consequence of the withdrawal, the extraordinary general meeting (EGM) originally slated for 8 April 2026 at 14:30 in Hangzhou has been cancelled. The company issued an apology to shareholders for any inconvenience caused.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang, Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, Ms. Yan Weiting) and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, Dr. Zhou Demin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJIUYUAN GENE Withdraws 2026 Share Award Scheme Resolutions and Cancels 8 Apr Extraordinary General Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-25 12:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The decision follows feedback from certain shareholders requesting additional time to evaluate the scheme. Management indicated that the share award programme is neither essential nor time-sensitive at this stage.</p>\n<p>As a direct consequence of the withdrawal, the extraordinary general meeting (EGM) originally slated for 8 April 2026 at 14:30 in Hangzhou has been cancelled. The company issued an apology to shareholders for any inconvenience caused.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang, Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, Ms. Yan Weiting) and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, Dr. Zhou Demin).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02566","symbol_name":"九源基因","start_time":0,"source_url":"","article_id":"1164747939","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164747939","pubTimestamp":1774412486,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02566":"九源基因"},"translate_title":"久远基因撤回2026年股份奖励计划决议案并取消4月8日临时股东大会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE) announced on 25 March 2026 that its board has withdrawn all resolutions related to the proposed 2026 Share Award Scheme. The decision follows feedback from certain shareholders requesting additional time to evaluate the scheme. Management indicated that the share award programme is neither essential nor time-sensitive at this stage.\nAs a direct consequence of the withdrawal, the extraordinary general meeting (EGM) originally slated for 8 April 2026 at 14:30 in Hangzhou has been cancelled. The company issued an apology to shareholders for any inconvenience caused.\nThe board currently comprises two executive directors (Mr. Fu Hang, Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, Ms. Yan Weiting) and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, Dr. Zhou Demin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}